At this point the move is to ask about his daughter’s business interests and allowing CMS to engage in pharmaceutical price negotiations pic.twitter.com/GijQvwdAnU— southpaw (@nycsouthpaw) September 29, 2021
At this point the move is to ask about his daughter’s business interests and allowing CMS to engage in pharmaceutical price negotiations pic.twitter.com/GijQvwdAnU